Acta Med. 2015, 58: 3-8

https://doi.org/10.14712/18059694.2015.84

Extracorporeal Elimination of Circulating Pegylated Liposomal Doxorubicin (PLD) to Enhance the Benefit of Cytostatic Therapy in Platinum-Resistant Ovarian Cancer Patients

Ondřej Kubečeka, Milan Bláhab, Daniel Diaz-Garciac, Stanislav Filipa

aDepartment of Oncology and Radiotherapy, Charles University in Prague, Medical Faculty and University Hospital in Hradec Králové, Czech Republic
b4th Department of Internal Medicine – Haematology, Charles University in Prague, Medical Faculty and University Hospital in Hradec Králové, Czech Republic
cDepartment of Histology and Embryology, Charles University in Prague, Medical Faculty and University Hospital in Hradec Králové, Czech Republic

Received November 20, 2014
Accepted April 1, 2015

Individual author index pages


Other articles of these authors

front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Open access journal

Archive